INTRODUCTION
A 60-year-old male is diagnosed with Parkinson's disease, a 50-year-old woman has breast cancer, a 30year-old male is obese with metabolic syndrome, a 20-year-old boy is infertile, a 9-year-old girl has asthma, and a 6-yr-old boy has learning disabilities. With all of these different diseases arising at various times across the lifespan, what could they have in common? The answer is not found in genetics; although there is a genetic component to these diseases, mutations and polymorphisms likely account for only small and variable risk. Instead, the common link between all these noncommunicable conditions is that they likely originated during early development as the result of environmental influences: altered nutrition, stress, drugs, infections, or exposure to environmental chemicals. This review will provide an overview of the developmental origins of health and disease, as well as focus on the latest data showing transgenerational transmission of disease susceptibility. Barker , who in the mid-1980s showed that starvation of pregnant women during the Dutch 'hunger winter' of the second world war correlated with an increased risk of cardiovascular and metabolic diseases in their offspring at adulthood [1] . Thus, the concept that poor nutrition during organ development could lead to an increased risk of disease later in life was originally called the Barker Hypothesis, then the Fetal Origin of Adult Disease, and now the Developmental Origins of Health and Disease (DOHaD). Although the original focus was on how fetal malnutrition contributes to adult hypertension, obesity and insulin resistance, newer studies have identified other diseases that can result from fetal over or under-nutrition including immunological, mental health, and reproductive diseases [2] [3] [4] [5] .
LINKING ENVIRONMENTAL EXPOSURES DURING DEVELOPMENT TO INCREASED DISEASE RISK ACROSS THE LIFESPAN
Work exploring the link between exposures to certain chemicals and drugs during early development and disease risk across the lifespan developed independently of the work on fetal malnutrition. The strongest data suggesting a link between developmental chemical exposures and later life diseases include smoking [6] , lead, methyl mercury [7] , and diethylstilbestrol (DES), a pharmaceutical estrogen [8] . A comprehensive literature search identified 343 published epidemiology studies (through mid-2013), which suggested associations between developmental chemical exposures and later life diseases; more than 180 studies assessed the linkage between an environmental chemical exposure and some aspect of neurodevelopment, including early life neurobehavioral and learning disabilities or IQ loss (Heindel, unpublished). For example, in 2011, three separate labs identified associations between prenatal exposures to organophosphate pesticides and altered IQ and cognitive development in separate cohorts of children [9] [10] [11] .
Animal studies have also provided important information showing that developmental exposures to environmental chemicals can induce diseases in later life; many of the diseases implicated in these animal studies have been increasing in human populations over recent decades and affect a large proportion of the population including obesity, neurodevelopmental diseases and dysfunctions, asthma, and immune dysfunctions [12, 13] . Animal studies also show causal relationships between developmental chemical exposures and diseases that have not been examined in human studies because of the long lag time between exposures and disease onset, such as breast and prostate cancer, neurodegenerative diseases, cardiovascular diseases and reproductive conditions including endometriosis, and uterine fibroids [13] [14] [15] .
SIMILARITIES BETWEEN DIFFERENT DEVELOPMENTAL DISTURBANCES AND DISEASE RISK
There are many features common to environmental influences during development including:
(1) There are specific sensitive windows of exposure leading to time-specific and tissue-specific effects. In general, increased sensitivity is noted during the time a specific tissue is forming, which can occur in utero or extends to the first years of life depending on the tissue. (2) The effects do not result in birth defects or malformations, which are apparent at birth. Instead, subtle functional changes include altered gene expression (which can lead to altered proteins), altered cell numbers, and altered metabolism. 
KEY POINTS
Evidence in support of the DOHaD paradigm is sufficiently robust and repeatable across species, including humans, to suggest a need for greater emphasis in the clinical area.
Environmental chemical exposure or nutritional stress during precise time periods of fetal development, in some cases, generate phenotypes in animal models, not only in the parental generation, but in the children, and sometimes in the grandchildren and greatgrandchildren.
Early interventions during the prenatal period and the first few postnatal years, the time when tissues are forming and the epigenetic system is most sensitive to environmental insults, have the potential to lead to improved lifelong health.
(6) Some effects can be transmitted via the germ line to subsequent generations resulting in multigenerational and transgenerational effects.
As both under-nutrition or over-nutrition and environmental chemical exposures have so much in common and likely occur together, it is imperative that all data are integrated to gain a real picture of the effect of altered developmental programming and disease outcomes across the lifespan.
MECHANISTIC UNDERSTANDING OF HOW DEVELOPMENTAL ENVIRONMENTAL STRESSORS CONTRIBUTE TO ADULT DISEASES
The increased sensitivity of the developmental period is thought to be a reflection of the plasticity of developing organisms. During early embryogenesis, pluripotent cells differentiate into all the cells and tissues of the body; this process is under the control of hormones and other signaling molecules such as growth factors. Changes in stress, nutrition, or exposure to infections, drugs, or a variety of environmental chemicals can alter the orchestrated process of cell differentiation.
Furthermore, environmental factors can influence the epigenome -the noncoding alterations that affect DNA and thus influence gene expression -which can predispose these cells and tissues to disease and dysfunction across the lifespan. Two well understood epigenetic mechanisms are DNA methylation near gene promoter regions and histone modifications. These modifications can control gene expression in an integrated and coordinated manner. For example, histone modifications and the recruitment of DNA regulatory proteins can lead to changes in transcription, but only if the gene promoter region is not methylated and is therefore open to transcription factor binding. This cross-talk is mediated by proteins that decipher the regulatory information that is encoded in the DNA methylation and histone marks [16] . The developmental periods encompassing gestation and the first few years of life are uniquely sensitive to environmental perturbations at least partly because of the sensitivity of epigenetic 'marks' to environmental influences during tissue differentiation. Once tissues are formed, the tissue epigenome, although somewhat dynamic, is relatively stable and therefore much less sensitive to environmental influences. Thus, each tissue will have a specific time -a 'critical window' -when it is highly sensitive to environmental influences on the epigenome. Some tissues fully develop before birth, whereas others like the brain, immune, and metabolic systems continue to develop into childhood.
Although a causal link between epigenetic changes and the increased susceptibility to disease later in life has not been established, epigenetics is a strong plausible molecular mechanism that links genes, environment, and the susceptibility to disease [17 && ,18,19,20 && ]. Indeed, supplementation or restriction of the maternal diet with dietary factors can alter epigenetic patterns in offspring [21, 22] . A large number of tissue-specific differentially methylated sites were observed in livers of mice exposed to nutritional stress during development [23] . Similarly, epigenetic alterations were observed in the prostate after neonatal exposure to bisphenol A (BPA) [24] . There is now a considerable body of literature demonstrating epigenetic changes that persist later in life from altered nutrition, stress, or environmental chemicals during development; these epigenetic changes may serve as biomarkers of increased disease susceptibility.
LINKING DEVELOPMENTAL EXPOSURES TO ENVIRONMENTAL STRESSORS TO DISEASES ACROSS GENERATIONS
One of the more fascinating and significant recent findings related to the DOHaD paradigm is that disease risk can be transmitted across generations. Most of this evidence has been generated in animal models. Transmission of disease risk from F0 (mother) to F1 (offspring) or F2 (grandchildren) is considered mutigenerational, and has significant implications for the transmission of diseases in humans. If the observed effects are also apparent in the F3 generation, then they cannot be because of direct effects of the environmental stressor, as the F3 individuals were never exposed to the compound at any time; these effects are likely to be permanent and transmitted further down the ancestral tree. Effects transmitted to the F3 generation or beyond are called transgenerational.
The mechanisms underlying transgenerational inheritance, while proposed to involve transmission of epigenetic information, is far from understood and likely involves other unidentified factors [25 && -27 && , 28,29 & ]. When primordial germ cells are developing, they are depleted of all epigenetic marks, allowing them to become pluripotent cells; epigenetic marks are added back in a timespecific and sex-specific manner. Thus, transmission of epigenetic information across generations is only possible if the epigenetic marks are not erased during germ cell reprogramming, which does appear to be the case for at least some methyl groups [30] .
Environmental chemicals administered during precise time periods of fetal development generate phenotypes in animal models, not only in the parental generation, but in the children, and sometimes in the grandchildren [31] . Some diseases or gene expression changes can even be found in the F3 generation (great-grandchildren) and beyond, presumably resulting from chemical exposures that affect DNA loci that escape reprogramming during gametogenesis [32] [33] [34] . Changes in the F3 generation sperm epigenome have been identified after developmental exposure to the fungicide vinclozolin [35] , dioxin [36] , the insecticide dichlorodiphenyltrichloroethane (DDT) [37] , a hydrocarbon mixture (jet fuel JP-8) [38] , and a pesticide/insect repellent mixture [permethrin and N, N-diethylmeta-toluamide (DEET)] [39] . Transgenerational effects on the incidence of ovarian diseases and testicular dysfunction have also been reported [40] . Other transgenerational effects that have been linked to chemical exposures include: effects of BPA on social behavioral changes in the F4 generation via epigenetic changes in imprinted genes [41] ; effects of the fungicide tributyl tin on adipose depot weight, adipocyte size, mesenchymal cell fate, and fatty liver in the F1, F2, and F3 generations [34] ; inheritance of obesity from exposure to DDT, a mixture of BPA and the plasticizer, Di(2-ethylhexyl)phthalate, and jet fuel JP-8 [36] [37] [38] . Collectively, these results demonstrate that the effects of early-life exposures to some environmental chemicals can be permanent and transgenerational, increasing the risk of future generations developing diseases including obesity, some cancers, and reproductive dysfunctions [42 && ]. The mechanism(s) for these effects are still unclear.
Intrauterine under-nutrition can also induce epigenetic changes in the F1 germ line, which are linked to alterations in the F2 generation and increased risk of metabolic syndrome [43] [44] [45] . Several groups found effects on the F2 generation when the pregnant dam (F0) was exposed to low-protein diets, calorie restriction, high-fat diets, or when gestational diabetes was induced; effects were observed on glucose tolerance, blood pressure and vascular dysfunction, body weight, insulin resistance, immune dysfunction, reproduction, and neurological dysfunctions [25 && ,26 && ,46] . Although the majority of these studies showed the transmission of effects through the maternal line, some effects were noted when only the father was exposed to the stressor [26 && ]. Most of these studies did not show transmission to the F3 generation, indicating a lack of true transgenerational inheritance; however, a few studies reported effects of high-fat or lowprotein diets on body weight, glucose tolerance, insulin secretion, and pancreatic beta cell mass in the F3 generation [26 && ] similar to that observed after environmental chemical exposures.
CONCLUSION
The evidence in support of the DOHaD paradigm is sufficiently robust and repeatable across species, including humans, to suggest a need for greater emphasis in the clinical area. Because of these data, obesity, diabetes, cardiovascular morbidity, and neurodegenerative diseases can all be considered pediatric diseases, not because they show up in children but because they originate during development. The importance to pediatricians is that the sensitive developmental window covers not just inutero exposures, but also early childhood. In some tissues, such as the brain and immune system, the developmental period is extended through puberty. Thus, for many diseases, it is clear that a new focus on the timing of disease prevention is needed. Early interventions during the prenatal period and the first few postnatal years, the time when tissues are forming and the epigenetic system is most sensitive to environmental insults, have the potential to lead to improved lifelong health. The targets for reducing the risk of disease across the lifespan and generations are the pregnant mother and their infants and young children through puberty. There are also recent data showing that exposures of the father can affect sperm epigenetics [47 & ] suggesting the possibility of paternal effects on disease susceptibility. The clinician is ultimately at the center of the battle to prevent diseases that occur across the lifespan and indeed even across generations.
The Endocrine Society [48, 49] , the American College of Obstetricians [50] , the American Society of Reproductive Medicine, and the Royal College of Obstetricians and Gynaecologists [51] , the European Society for Paediatric Endocrinology and the US Pediatric Endocrine Society [52] , and other scientific groups [13] have put forward statements calling for action on environmental chemicals due to the sensitivity of developing individuals and the resulting increased disease risk across the lifespan. They also call for a focus on disease prevention. Improving and optimizing nutrition, reducing stress, drugs, infections, and exposure to environmental chemicals during pregnancy and early childhood offer an opportunity to reduce the risk of many communicable diseases Finally, it should be noted that although development is a sensitive period for the effects of environmental influences on disease risk, there are likely other periods during the lifespan that Developmental origins of health and disease Heindel and Vandenberg are important. These may include other periods with major changes in hormones and growth such as the period of infancy to childhood, puberty, perimenopause, pregnancy, and aging [16] . It is not clear how important each of these transition periods are to disease risk or how they might interact.
As noted by Silver and Singer [53] , investing in child development is the foundation for improved health, economic, and social outcomes. Embracing the DOHaD paradigm provides an opportunity for both patients and physicians to prevent diseases and intervene to lessen their impact, and to take action years before disease onset is evident.
